Advertisement
Research Article Free access | 10.1172/JCI112877
Find articles by Broxmeyer, H. in: JCI | PubMed | Google Scholar
Find articles by Williams, D. in: JCI | PubMed | Google Scholar
Find articles by Cooper, S. in: JCI | PubMed | Google Scholar
Find articles by Shadduck, R. in: JCI | PubMed | Google Scholar
Find articles by Gillis, S. in: JCI | PubMed | Google Scholar
Find articles by Waheed, A. in: JCI | PubMed | Google Scholar
Find articles by Urdal, D. in: JCI | PubMed | Google Scholar
Find articles by Bicknell, D. in: JCI | PubMed | Google Scholar
Published March 1, 1987 - More info
Purified murine colony-stimulating factors (CSF) recombinant interleukin 3 (IL-3), natural CSF-1, and recombinant granulocyte-macrophage (GM) CSF were assessed in vivo for their effects on BDF1 mouse bone marrow and spleen granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells in untreated mice and in mice pretreated with purified iron-saturated human lactoferrin (LF). The CSF and LF preparations did not contain detectable endotoxin (less than 0.1 ng). Mice pretreated with LF were more sensitive to the effects of CSF. In mice pretreated with LF, 2,000 U IL-3 or 20,000 U CSF-1 significantly enhanced the cycling status and absolute numbers of all progenitors, whereas 20,000 U GM-CSF significantly increased the cycling status of CFU-GM and CFU-GEMM, but had no effect on cycling of BFU-E or on numbers of any of the progenitors. The effects of CSF in mice pretreated with LF were not mimicked by 0.1-100 ng E. coli lipopolysaccharide.